[email protected] | |
3275638434 | |
Paper Publishing WeChat |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Sevgi Kolaylı1, Nimet Baltas2, Huseyin Sahin3 and Sengul Karaoglu4
Full-Text PDF XML 1783 Views
DOI:10.17265/2159-5828/2017.02.001
1. Department of Chemistry, Faculty of Science, Karadeniz Technical University, Trabzon 61080, Turkey
2. Department of Chemistry, Faculty of Arts and Science, Recep Tayyip Erdogan University, Rize 53100, Turkey
3. Espiye Vocational School, Giresun University, Espiye/Giresun 28600, Turkey
4. Department of Biology, Faculty of Arts and Science, Recep Tayyip Erdogan University, Rize 53100, Turkey
Infection with Helicobacter pylori (H. pylori) is an important known risk factor for gastric disease. At least half the world’s population is under the influence of this bacterium type. So many therapeutic studies focus on treat gastric disease. But these treatments could be interrupted due to metabolic toxic and show the drug resistance. The objective of this study was to investigate the effecting degree of H. pylori with different type of honey samples from Turkey. The study was supported by bioactivity results of total phenolic (TPC) and flavonoid content (TFC). The agar-well diffusion assay was carried out on H. pylori strain J99 and the inhibition zones were measured and compared with standards. Inhibition of H. pylori urease as IC50 ranged from 2.67-18.12 mg/mL. These results were supported by TPC and TFC had range from 22.10-79.00 mg Gallic Acid Equivalent (GAE)/100 honey and 0.88-7.08 mg Quercetin Equivalent (QE)/100 g honey, respectively. These results indicate that honey extracts may be appropriate agents to treat H. pylori by inhibition effect.
Honey, anti-Helicobacter pylori, urease inhibition, antimicrobial.